DrugPatentWatch Database Preview
Reserpine - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for reserpine and what is the scope of freedom to operate?
Reserpine
is the generic ingredient in thirteen branded drugs marketed by Novartis, Lilly, Bowman Pharms, Bristol Myers Squibb, Barr, Bell Pharma, Bundy, Cycle Pharms Ltd, Elkins Sinn, Everylife, Halsey, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Marshall Pharma, Mk Labs, Mylan, Pharmavite, Purepac Pharm, Pvt Form, Rexall, Sandoz, Solvay, Tablicaps, Teva, Valeant Pharm Intl, Watson Labs, Whiteworth Town Plsn, Lannett, Panray, Vale, Vitarine, Sanofi Aventis Us, and Schering, and is included in forty-three NDAs. Additional information is available in the individual branded drug profile pages.There are nineteen drug master file entries for reserpine.
Summary for reserpine
| US Patents: | 0 |
| Tradenames: | 13 |
| Applicants: | 34 |
| NDAs: | 43 |
| Drug Master File Entries: | 19 |
| Bulk Api Vendors: | 73 |
| Clinical Trials: | 13 |
| Patent Applications: | 8,972 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | reserpine at DailyMed |
Recent Clinical Trials for reserpine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mansoura University | Phase 4 |
| Mayo Clinic | Phase 1 |
| University of Alabama at Birmingham | Phase 2 |
Medical Subject Heading (MeSH) Categories for reserpine
Synonyms for reserpine
| .gamma.-Serpine |
| (-)-Reserpine |
| (1S,2R,3R,4aS,13bR,14aS)-methyl 2,11-dimethoxy-3-((3,4,5-trimethoxybenzoyl)oxy)-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate |
| (3?,16?,17?,18?,20?)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester |
| (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16- carboxylic acid methyl ester |
| (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester |
| 005R091 |
| 11,17-Dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)yohimban-16-carboxylic acid methyl ester |
| 1407-38-1 |
| 141099-49-2 |
| 146088-EP2287158A1 |
| 146088-EP2292597A1 |
| 3-.beta., 18-.beta.-hydroxy-11,17-.alpha.-dimethoxy-,methyl ester, 3,4,5-trimethoxybenzoate (ester) |
| 3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-11,17-alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) |
| 3-beta,20-alpha-yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-11,17-alpha-dimethoxy-, methyl ester,3,4,5-trimethoxybenzoate (ester) |
| 3,4,5-Trimethoxybenzoyl methyl reserpate |
| 3,5-Trimethoxybenzoyl methyl reserpate |
| 3.beta., 18.beta.-hydroxy-11,17.alpha.-dimethoxy- methyl ester 3,4,5-trimethoxybenzoate (ester) |
| 3beta,20alpha-Yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy- methyl ester 3,4,5-trimethoxybenzoate (ester) |
| 3beta,20alpha-Yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy- methyl ester 3,4,5-trimethoxybenzoate (ester) (8CI) |
| 3beta,20alpha-yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) |
| 3P Reserp |
| 4-25-00-01319 (Beilstein Handbook Reference) |
| 50-55-5 |
| 79 more names available |
| 8048-25-7 |
| 873409-80-4 |
| 8B1QWR724A |
| 909883-12-1 |
| 91098-EP2275420A1 |
| 91098-EP2305219A1 |
| 911481-85-1 |
| AB01562943_01 |
| AB2000152 |
| Abesta |
| Abicol |
| ABP000583 |
| AC-13142 |
| AC1L1L3K |
| ACon1_000086 |
| Adelfan |
| Adelphin |
| AI3-50146 |
| AKOS000277559 |
| Alkarau |
| Alkaserp |
| Alserin |
| AN-41564 |
| AOB5791 |
| Apoplon |
| Apoplon (TN) |
| Apsical |
| Ascoserp |
| Ascoserpina |
| Austrapine |
| Banasil |
| Banisil |
| BBL028800 |
| BDBM50017712 |
| Benazyl |
| Benz[g]indolo[2, 1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-3-hydroxy-2,11-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate |
| Bioserpine |
| BPBio1_001045 |
| BRD-K95921201-001-07-0 |
| Brinderdin |
| Briserine |
| BRN 0102014 |
| Broserpine |
| BSPBio_000949 |
| Butiserpazide-25 |
| C06539 |
| Cardioserpin |
| Carditivo |
| Carpacil |
| Carrserp |
| CAS-50-55-5 |
| Caswell No. 722A |
| CCG-204168 |
| CCRIS 550 |
| CHEBI:28487 |
| CHEMBL772 |
| Chloroserp-250 |
| Chloroserp-500 |
| Chloroserpin-250 |
| Chloroserpine-500 |
| component of Butiserpazide |
| component of Metatensin |
| component of Naquival |
| component of Regroton |
| component of Renese R |
| Crystoserpine |
| CS-1913 |
| D00197 |
| Darebon |
| DB00206 |
| Deserpine |
| Diupres |
| Diupres 250 |
| Diupres 500 |
| Diupres-250 |
| Diupres-500 |
| Diurese-R |
| Diutensen-R |
| DivK1c_000012 |
| Dralserp |
| DSSTox_CID_1237 |
| DSSTox_GSID_21237 |
| DSSTox_RID_76029 |
| DTXSID7021237 |
| Eberpine |
| Eberspine |
| Ebserpine |
| EINECS 200-047-9 |
| Elfanex |
| Elserpine |
| Enipresser |
| ENT 50146 |
| EPA Pesticide Chemical Code 123101 |
| esc aspere |
| Escaspere |
| Eserpine |
| Eskaserp |
| Eskaserpine |
| EU-0100073 |
| gammaserpine |
| Gilucard |
| GTPL4823 |
| H 520 |
| H.R.-50 |
| Helfoserpin |
| Hexaplin |
| Hiposerpil |
| Hiserpia |
| HMS1570P11 |
| HMS1920P04 |
| HMS2092G05 |
| HMS2097P11 |
| HMS2234E24 |
| HMS3260O07 |
| HMS3714P11 |
| HMS500A14 |
| HSDB 213 |
| HY-N0480 |
| Hydro-Fluserpine #1 |
| HYDRO-RESERP |
| Hydro-Reserpine-25 |
| Hydro-Reserpine-50 |
| HYDRO-SERP "25" |
| HYDRO-SERP "50" |
| HYDROCHLOROTHIAZIDE W/ RESERPINE |
| Hydromox R |
| Hydromox-R |
| Hydropine |
| Hydropres 25 |
| Hydropres 50 |
| Hydroserp |
| Hydroserpalan |
| Hydroserpine #1 |
| Hydroserpine Plus |
| Hydrosine 25 |
| Hypercal B |
| Hypersil |
| Hypersine |
| Hypertane forte |
| Hypertensan |
| IDI1_000012 |
| Idoserp |
| Idsoserp |
| Interpina |
| J10192 |
| KBio1_000012 |
| KBio2_000549 |
| KBio2_003117 |
| KBio2_005685 |
| KBio3_001808 |
| KBioGR_001397 |
| KBioSS_000549 |
| Key-serpine |
| Kitine |
| Klimanosid |
| KS-5106 |
| l -Carpserp |
| l-Carpserp |
| l"-Carpserp |
| Lemiserp |
| Lopac0_000073 |
| loweser p |
| Loweserp |
| LP00073 |
| LS-1306 |
| Mallopress |
| Marnitension simple |
| Maviserpin |
| Mayserpine |
| MCULE-9131256292 |
| MCULE-9946449258 |
| MEGxp0_001904 |
| Mephaserpin |
| Metatensin #2 |
| Metatensin #4 |
| methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate |
| methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate |
| methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(3,4,5-trimethoxyphenyl)carbonyloxy]-3,13-diazapentacyclo[11.8.0.0;{2,10}.0;{4,9}.0;{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate |
| methyl (1S,2R,3R,4aS,13bR,14aS)-2,11-dimethoxy-3-((3,4,5-trimethoxybenzoyl)oxy)-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate |
| methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-bis(methyloxy)-18-({[3,4,5-tris(methyloxy)phenyl]carbonyl}oxy)yohimban-16-carboxylate |
| methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate |
| methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-{[(3,4,5-trimethoxyphenyl)carbonyl]oxy}yohimban-16-carboxylate |
| methyl 11,17alpha-dimethoxy-18beta-(3,4,5-trimethoxybenzoyloxy)-3beta,20alpha-yohimbane-16beta-carboxylate |
| Methyl 18beta-hydroxy-11,17alpha-dimethoxy-3beta,20alpha-yohimban-16beta-carboxylate 3,4,5-trimethoxybenzoate (ester) |
| methyl dimethoxy-(3,4,5-trimethoxybenzoyl)oxy-[?]carboxylate |
| methyl o-(3,4,5-trimethoxybenzo yl)reserpate |
| methyl o-(3,4,5-trimethoxybenzoyl)reserpate |
| Methyl reserpate 3,4,5-trimethoxybenzoate (ester) |
| Methyl reserpate 3,4,5-trimethoxybenzoic acid ester |
| Methyl reserpate 3,5-trimethoxybenzoic acid ester |
| Methyl reserpate 3,5-trimethyloxybenzoic acid |
| Methyl reserpate; 3,4,5-Trimethoxybenzoic acid ester |
| Methylreserpate 3,4,5-trimethoxybenzoic acid |
| Methylreserpate 3,4,5-Trimethoxybenzoic acid ester |
| MFCD00005091 |
| MLS002154046 |
| MLS006011754 |
| Modenol |
| MolPort-000-881-944 |
| Naquival |
| NCGC00091250-01 |
| NCGC00091250-02 |
| NCGC00091250-03 |
| NCGC00091250-04 |
| NCGC00091250-05 |
| NCGC00091250-06 |
| NCGC00091250-07 |
| NCGC00091250-08 |
| NCGC00091250-09 |
| NCGC00091250-10 |
| NCGC00091250-12 |
| NCGC00091250-14 |
| NCGC00254489-01 |
| NCGC00259944-01 |
| NCGC00260758-01 |
| NCI-C50157 |
| NCI60_004446 |
| nembuserpin |
| Neo-antitensol |
| neo-serp |
| neose rfin |
| Neoserfin |
| Neoserp |
| Neoslowten |
| NINDS_000012 |
| Novoreserpine |
| NSC 237659 |
| NSC-237659 |
| NSC-59272 |
| NSC-757309 |
| NSC237659 |
| NSC59272 |
| NSC757309 |
| Orthoserpina |
| Perskleran |
| Pharmakon1600-01500526 |
| Pressimedin |
| Prestwick_147 |
| Prestwick0_000875 |
| Prestwick1_000875 |
| Prestwick2_000875 |
| Prestwick3_000875 |
| Purserpine |
| Q-100566 |
| QEVHRUUCFGRFIF-MDEJGZGSSA-N |
| Quiescin |
| R 0875 |
| R-e-s |
| rau sedyl |
| Rau-Sed |
| Raucap |
| Raudiford |
| Raudixin |
| Raudixoid |
| Raugal |
| Raulen |
| Rauloydin |
| Raumorine |
| Raunervil |
| Raunorine |
| Raunova |
| Raupasil |
| Raupoid |
| Raurine |
| Rausan |
| Rausedan |
| Rausedil |
| Rausedyl |
| Rauserpin |
| Rauserpin-Alk |
| Rauserpine |
| Rauserpol |
| Rausingle |
| Rautrin |
| Rauvlid |
| Rauwasedin |
| Rauwilid |
| Rauwiloid |
| Rauwipur |
| Rauwita |
| Rauwoleaf |
| Rawilid |
| RCRA waste no. U200 |
| Rcra waste number U200 |
| Recipin |
| Regroton |
| Renese R |
| Renese-R |
| Resaltex |
| rese rpamed |
| Rese-lar |
| Resedrex |
| Resedril |
| Reser-ar |
| Reserbal |
| Resercaps |
| Resercen |
| Reserfia |
| Reserjen |
| Reserlor |
| Reserp |
| Reserpal |
| Reserpamed |
| Reserpanca |
| Reserpene |
| Reserpex |
| Reserpic acid methyl ester 3,4,5-trimethoxybenzoate (ester) |
| Reserpidefe |
| Reserpil |
| Reserpin |
| Reserpina |
| Reserpina [INN-Spanish] |
| Reserpine (JP17/USP/INN) |
| Reserpine [USAN:INN:BAN:JAN] |
| Reserpine [USP:INN:BAN:JAN] |
| RESERPINE AND HYDROCHLOROTHIAZIDE |
| RESERPINE AND HYDROCHLOROTHIAZIDE-50 |
| Reserpine solution, 1 pg/muL in methanol: water (1:1) |
| Reserpine Standard for LC-MS, analytical standard, for LC-MS |
| Reserpine, 99% |
| Reserpine, certified reference material, TraceCERT(R) |
| Reserpine, crystallized, >=99.0% (HPLC) |
| Reserpine, European Pharmacopoeia (EP) Reference Standard |
| Reserpine, Pharmaceutical Secondary Standard; Certified Reference Material |
| Reserpine, United States Pharmacopeia (USP) Reference Standard |
| Reserpine, Vetec(TM) reagent grade |
| Reserpine,(S) |
| Reserpine/ |
| Reserpinum |
| Reserpka |
| Reserpoid |
| Reserpur |
| Reserutin |
| Resiatric |
| Residin |
| Residine |
| Resine |
| Resocalm |
| Resperin |
| Resperine |
| Respital |
| Restran |
| Rezerpin |
| Riserpa |
| Rivased |
| Rivasin |
| RKL10049 |
| Rolserp |
| Roxel |
| Roxinoid |
| Roxynoid |
| Ryser |
| Salupres |
| Salutensin |
| Salutensin-Demi |
| Sandril |
| Sandron |
| SBI-0050061.P004 |
| SC-18569 |
| SCHEMBL2589 |
| se rpate |
| Sedaraupin |
| Sedaraupina |
| Sederaupin |
| Sedserp |
| Seominal |
| Serfin |
| Serfolia |
| Serolfia |
| Serp-AFD |
| Serpalan |
| Serpalan (TN) |
| Serpaloid |
| Serpaneurona |
| Serpanray |
| Serpasil |
| Serpasil premix |
| Serpasil-apresoline |
| Serpasil-Esidrix #1 |
| Serpasil-Esidrix #2 |
| Serpasol |
| Serpate |
| Serpazil |
| Serpazol |
| Serpedin |
| Serpen |
| Serpena |
| Serpentil |
| Serpentin |
| Serpentina |
| Serpicon |
| Serpil |
| Serpiloid |
| Serpilum |
| Serpine |
| Serpine (pharmaceutical) |
| Serpipur |
| Serpivate |
| Serpivite |
| Serpogen |
| Serpoid |
| Serpone |
| Serpyrit |
| Sertabs |
| Sertens |
| Sertensin |
| Sertina |
| SK-Reserpine |
| SMR000059122 |
| Solfo serpine |
| SPBio_002870 |
| Spectrum_000109 |
| SPECTRUM1500526 |
| Spectrum3_000894 |
| Spectrum4_000989 |
| Spectrum5_001415 |
| STK801975 |
| Supergan |
| SW196458-3 |
| T-Serp |
| Tefaserpina |
| Tempo-Reserpina |
| Temposerpine |
| Tensanyl |
| Tenserpinie |
| Tensional |
| Tensionorme |
| Tepserpine |
| Terbolan |
| Tox21_111107 |
| Tox21_111107_1 |
| Tox21_202395 |
| Tox21_300537 |
| Tox21_500073 |
| Transerpin |
| Trimethoxybenzoyl methyl reserpate |
| Triserpin |
| Tylandril |
| UNII-8B1QWR724A |
| Unilord |
| UNM000011053801 |
| Usaf cb-27 |
| V-Serp |
| Veriloid |
| VI XO |
| Vio-Serpine |
| VIXO |
| WLN: T F6 D5 C666 EM ON&&TTTJ HO1 SOVR CO1 DO1 EO1& TO1 UVO1 |
| yohimban-16-carboxylic acid derivative of benz[g]indolo[2,3-a]quinolizine |
| Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)- |
| Yohimban-16-carboxylic acid,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3.beta.,16.beta.,17.alpha.,18.beta.,20.alpha.)- |
| ZINC3938746 |
US Patents and Regulatory Information for reserpine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | SANDRIL | reserpine | TABLET;ORAL | 009376-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Whiteworth Town Plsn | RESERPINE | reserpine | TABLET;ORAL | 080723-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Bundy | RESERPINE | reserpine | TABLET;ORAL | 009663-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Watson Labs | RESERPINE | reserpine | TABLET;ORAL | 085401-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Cycle Pharms Ltd | RESERPINE | reserpine | TABLET;ORAL | 009859-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Novartis | SERPASIL | reserpine | TABLET;ORAL | 009115-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
